|
|
|
|
|
|
|
|
|
|
New Articles -- EvidenceUpdates
"CONCLUSION: The use of bevacizumab was significantly associated with an increased risk of developing venous thromboembolism in cancer patients receiving this drug."
Friday, November 28, 2008
EvidenceUpdates - Risk of Venous Thromboembolism with the Angiogenesis Inhibitor Bevacizumab (Avastin) in Cancer Patients: A Meta-analysis
New Articles -- EvidenceUpdates
"CONCLUSION: The use of bevacizumab was significantly associated with an increased risk of developing venous thromboembolism in cancer patients receiving this drug."
Subscribe to:
Post Comments
(
Atom
)
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.